These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10366725)

  • 1. Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects.
    Dalpiaz A; Ferretti ME; Pecoraro R; Fabbri E; Traniello S; Scatturin A; Spisani S
    Biochim Biophys Acta; 1999 Jun; 1432(1):27-39. PubMed ID: 10366725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
    Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
    Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational aspects of human formylpeptide receptor antagonists.
    Scatturin A; Vertuani G; Pecoraro R; Dalpiaz A; Boggian M; Ferretti ME; Spisani S
    Arzneimittelforschung; 1999 Oct; 49(10):873-7. PubMed ID: 10554666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors.
    Dalpiaz A; Scatturin A; Vertuani G; Pecoraro R; Borea PA; Varani K; Traniello S; Spisani S
    Eur J Pharmacol; 2001 Jan; 411(3):327-33. PubMed ID: 11164392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
    Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
    J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational aspects of human formyl-peptide receptor agonists.
    Dalpiaz A; Vertuani G; Scatturin A; Vitali F; Varani K; Spisani S
    Arzneimittelforschung; 2003; 53(11):793-8. PubMed ID: 14677376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues.
    Derian CK; Solomon HF; Higgins JD; Beblavy MJ; Santulli RJ; Bridger GJ; Pike MC; Kroon DJ; Fischman AJ
    Biochemistry; 1996 Jan; 35(4):1265-9. PubMed ID: 8573582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two classes of non-peptide drugs as antagonists of neutrophil receptors for f-Met-Leu-Phe. Pyrazolons and iodinated radiographic contrast agents.
    Levesque L; Gaudreault RC; Marceau F
    Biochem Pharmacol; 1992 Feb; 43(3):553-60. PubMed ID: 1311583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute ethanol intoxication regulates f-met-leu-phe-induced chemotaxis and superoxide release by neutrophils and Kupffer cells through modulation of the formyl peptide receptor in the rat.
    Bautista AP; Elliott KE
    Life Sci; 1994; 54(11):721-30. PubMed ID: 8107522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.
    Cavicchioni G; Fraulini A; Turchetti M; Varani K; Falzarano S; Pavan B; Spisani S
    Eur J Pharmacol; 2005 Apr; 512(1):1-8. PubMed ID: 15814083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.
    Mollica A; Feliciani F; Stefanucci A; Costante R; Lucente G; Pinnen F; Notaristefano D; Spisani S
    J Pept Sci; 2012 Jun; 18(6):418-26. PubMed ID: 22528501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N alpha-formylated and tert-butyloxycarbonylated Phe-(Leu-Phe)n and (Leu-Phe)n peptides as agonists and antagonists of the chemotactic formylpeptide receptor of the rabbit peritoneal neutrophil.
    Toniolo C; Crisma M; Moretto V; Freer RJ; Becker EL
    Biochim Biophys Acta; 1990 Apr; 1034(1):67-72. PubMed ID: 2328263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.
    Pagani Zecchini G; Nalli M; Mollica A; Lucente G; Paglialunga Paradisi M; Spisani S
    J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
    Gao JL; Becker EL; Freer RJ; Muthukumaraswamy N; Murphy PM
    J Exp Med; 1994 Dec; 180(6):2191-7. PubMed ID: 7964494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.
    Seifert R; Schultz G; Richter-Freund M; Metzger J; Wiesmüller KH; Jung G; Bessler WG; Hauschildt S
    Biochem J; 1990 May; 267(3):795-802. PubMed ID: 2160237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues.
    Ferretti ME; Nalli M; Biondi C; Colamussi ML; Pavan B; Traniello S; Spisani S
    Cell Signal; 2001 Apr; 13(4):233-40. PubMed ID: 11306240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formylpeptide receptor antagonists: structure and activity.
    Dalpiaz A; Pecoraro R; Vertuani G; Spisani S; Rizzuti O; Fabbri E; Scatturin A
    Boll Chim Farm; 1999 Mar; 138(3):44-8. PubMed ID: 10394703
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of the N-formyl-Met-Leu-Phe receptor in human neutrophils with a GTP-binding protein sensitive to pertussis toxin.
    Lad PM; Olson CV; Smiley PA
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):869-73. PubMed ID: 2983319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leukocytes: a study of the structure-activity relationship.
    Levesque L; Gaudreault RC; Marceau F
    Can J Physiol Pharmacol; 1991 Mar; 69(3):419-25. PubMed ID: 1647850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.